Start Submission Become a Reviewer

Reading: Palatal Tremor – Pathophysiology, Clinical Features, Investigations, Management and Future C...


A- A+
Alt. Display


Palatal Tremor – Pathophysiology, Clinical Features, Investigations, Management and Future Challenges


Shakya Bhattacharjee

Neurology, Plymouth Hospital NHS Trust, GB
X close


Background: Palatal tremor is involuntary, rhythmic and oscillatory movement of the soft palate. Palatal tremor can be classified into three subtypes; essential, symptomatic and palatal tremor associated with progressive ataxia.

Methods: A thorough Pubmed search was conducted to look for the original articles, reviews, letters to editor, case reports, and teaching neuroimages, with the keywords “essential”, “symptomatic palatal tremor”, “myoclonus”, “ataxia”, “hypertrophic”, “olivary” and “degeneration”.

Results: Essential palatal tremor is due to contraction of the tensor veli palatini muscle, supplied by the 5th cranial nerve. Symptomatic palatal tremor occurs due to the contraction of the levator veli palatini muscle, supplied by the 9th and 10th cranial nerves. Essential palatal tremor is idiopathic, while symptomatic palatal tremor occurs due to infarction, bleed or tumor within the Guillain-Mollaret triangle. Progressive ataxia and palatal tremor can be familial or idiopathic. Symptomatic palatal tremor and sporadic progressive ataxia with palatal tremor show signal changes in inferior olive of medulla in magnetic resonance imaging. The treatment options available for essential palatal tremor are clonazepam, lamotrigine, sodium valproate, flunarizine and botulinum toxin. The treatment of symptomatic palatal tremor involves the treatment of the underlying cause.

Discussion: Further studies are required to understand the cause and pathophysiology of Essential palatal tremor and progressive ataxia and palatal tremor. Similarly, the link between tauopathy and palatal tremor associated progressive ataxia needs to be explored further. Oscillopsia and progressive ataxia are more debilitating than palatal tremor and needs new treatment approaches.

How to Cite: Bhattacharjee S. Palatal Tremor – Pathophysiology, Clinical Features, Investigations, Management and Future Challenges. Tremor and Other Hyperkinetic Movements. 2020;10:40. DOI:
  Published on 08 Oct 2020
 Accepted on 21 Sep 2020            Submitted on 06 May 2020


A tremor is an involuntary, rhythmic and oscillatory movement of one or more body parts at a fixed amplitude and frequency [1, 2, 3]. A palatal tremor (PT) is a rare type of tremor involving the soft palate. It can be unilateral or bilateral [1, 2]. Previously, palatal tremor was known as palatal myoclonus but it was subsequently renamed ‘palatal tremor’ during the First International Congress of Movement Disorders to acknowledge the continuous and rhythmic nature of the palatal movement (although it should be noted that segmental myoclonus can also be rhythmic). Palatal tremors do not oscillate around a point, unlike any other type of tremor. Palatal tremors can have huge variability in frequency (20–420 cycles/in), unlike other commonly-described tremors [3]. Despite these controversies, ‘palatal tremor’ is the most widely accepted term.

Two types of palatal tremor are described in the literature: essential palatal tremor (EPT) and symptomatic palatal tremor (SPT). EPT reveals no underlying structural pathology [3, 4]. SPT happens due to any lesion within the dentato-rubral-olivary pathway [1, 3]. Progressive ataxia and palatal tremor (PAPT) is traditionally considered to be a special subtype of SPT where the ataxia worsens independent of the tremor [1, 3]. Each subtype of palatal tremor has different aetiologies, clinical features and prognosis.


A thorough Pubmed search was conducted to look for original articles, reviews, letters to the editor, case reports and teaching neuroimages of relevance. The keywords used were ‘essential”, ‘’symptomatic”, “palatal”, “tremor”, “myoclonus”, “ataxia”,’’ hypertrophic”, “olivary” and “degeneration.”

Results and discussion

PT is classified according to the aetiology, mechanism (i.e. which muscles are responsible) and the radiological features (the presence of inferior olivary hypertrophy or not) [1, 2, 3]. In 1949, Stern et al. suggested that PT was the human homolog of a primitive accessory respiratory reflex in gill-breathing vertebrates [5]. EPT can be triggered by central, nasopharyngeal, psychogenic and peripheral stimulation [3, 4] On the other hand, SPT occurs due to a lesion in the dentato-rubral-olivary pathway, manifesting as the hypertrophic olivary degeneration of the medulla.

PAPT is characterised by the progression of ataxia in patients with PT. Some authors reported PAPT as a disorder of undetermined/degenerative aetiology and not due to an identifiable brain stem lesion [6, 7]. However, the delayed and progressive worsening of cerebellar function associated with SPT secondary to the identified structural lesion has also been reported in the literature [8]. These patients could equally be classified as having a PAPT syndrome with an identifiable lesion [9]. Sporadic PAPT can similarly be classified as either idiopathic or essential [10].

It is preferable to consider PAPT as a third category of PT, instead of considering it to be a subtype of SPT to avoid inconsistency and confusion. However, difficulty with the classification is likely to persist unless post-mortem histopathology or advanced imaging modalities become widely available.

Pathogenesis of essential palatal tremor (EPT)

I. Central origin

No clear structural pathology is found on magnetic resonance imaging (MRI) in patients with EPT but a functional MRI revealed potential generators of tremor in the inferior olive and brainstem [11]. Alhough this observation pointed towards a potential single generator for both EPT and SPT, the final pathway for the two tremors is different [1, 2, 3]. EPT is triggered by the contraction of the tensor veli palatini (TVP) muscle. The TVP is supplied by the trigeminal (5th cranial) nerve [2]. Another observation to support the central origin of the EPT is the response of said tremors to centrally-acting drugs like lamotrigine, sodium valproate and falunarizine [12, 13, 14]. However, these were presented through anecdotal evidence and no placebo-controlled trial was ever conducted to assess the true response.

II. Peripheral origin

The inflammation of the oral and nasal mucosa was found to be common among the patients with EPT. It was reported that EPT could be triggered by an upper respiratory tract infection [3, 15]. EPT was also reported to have been cured after an adenoidectomy and tonsillectomy [3]. EPT can also be influenced by pressure changes in the ear canal and by the changes in the tone and position of the pharyngeal muscles [16, 17]. However, such continuous movements cannot be maintained for prolonged periods in the absence of a central generator. The ear click is an important clinical feature of the EPT [1, 2, 3, 12, 13, 14]. If a peripheral inflammation is the sole trigger for ear click, then it should appear with the tremor [18]. However, a peripheral insult can act as a potential trigger of the central tremor generator [3, 4].

III. Voluntary

Some people can voluntarily contract the TVP, the main muscle involved in EPT. Klein et al. reported a family where the members could voluntarily produce a palatal tremor without any structural pathology of the peripheral or central nervous system [19]. Such people have probably acquired control over the central tremor generator part of the brain. These voluntary movements can be seen in tic disorders or psychogenic movement disorder, although prolonged maintenance of the rhythmical movements is rare in tics [3].

IV. Psychogenic

A psychogenic origin of EPT has been reported [20, 21]. Unlike voluntary EPT, patients with psychogenic EPT are more distressed by such movements. The common triggers for psychogenic origin are emotional stress or previous trauma. Many such patients demonstrated classic clinical signs of psychogenic disorders like distractibility, entertainability and variability. However, sometimes these clinical features can also be seen in non-psychogenic EPT, making the distinction difficult [21, 22]. Many such patients have no obvious psychiatric co-morbidities or other psychogenic movement disorders [3, 22].

Pathogenesis of symptomatic palatal tremor (SPT)

SPT is triggered by the contraction of the levator veli palatini muscle (LVP). The LVP is supplied by the 9th and 10%th cranial nerves. SPT arises from a lesion within the Guillain Mollaret triangle (GMT) (Figure 1) [1, 10, 23, 24, 25, 26, 27]. The GMT is a conceptual triangle in the brainstem. The GMT has three corners i.e. the red nucleus (RN) of the ipsilateral midbrain, the inferior olivary nucleus (ION) of the ipsilateral medulla and the dentate nucleus of the contralateral cerebellum [1, 25, 26, 27]. The central tegmental tract CTT) connects the RN to the ION. The dentatorubral tract connects the RN to the contralateral dentate nucleus via the superior cerebellar peduncle (SCP). The inferior cerebellar peduncle (ICP) joins the ION to the contralateral dentate nucleus (DN) [1, 23, 24, 25, 26, 27, 28].

Figure 1 

The Guillain-Mollaret Triangle (1A-schematic in the left and coronal Magnetic resonance imaging on the right-1B) -formed by the Red Nucleus (RN), Dentate Nucleus (DN) of the Cerebellum, Inferior Olivary Nucleus (ION), SCP – Superior Cerebellar Peduncle (connects the DN to the RN), ICP – Inferior Cerebellar Peduncle (connects the DN to the ION), CTT – Central Tegmental Tract (connects RN to the ION).

ION hypertrophy appears after 4–6 months of the initial insult [24, 25, 26, 27, 28]. The ION undergoes trans-synaptic degeneration characterised by the hypertrophy of the ION [24, 25, 28, 29]. This hypertrophic olivary degeneration (HOD) represents the vacuolation of the ION and the enlargement of the cell bodies resulting from a lesion of the GMT [24, 26, 27, 28]. When the primary lesion is in the dentato-rubral tract of SCP, the HOD is contralateral. However, bilateral HOD happens when both the CTT and SCP are involved [24].

The DN is connected to the contralateral ION by the GABA (gamma amino butyric acid) -ergic inhibitory projections which in turn send the excitatory projections to the Purkinje cells of the cerebellum [27]. The neurons within the ION are interconnected by the gap junctions and they can act as an asynchronised neuronal ensemble in normal circumstances [1]. These oscillations work as pacemakers in timely processing, temporal co-ordination, and cerebellar motor learning. The denervated olivary neurons released from the inhibitory inputs enlarge and develop sustained synchronised oscillations leading to the palatal tremor. The appearance of SPT may depend on the hyperactivity of the olivary neurons released from inhibitory inputs until the peak of both IOH and SPT is reached [25, 26]. Nishie et al. postulated that the persistence of peak intensity and the distribution of SPT is likely due to both the disturbance of the natural rhythmicity of the body and the lack of feedback from the abnormal movement resulting from the dysfunction of the olive [29]. SPT appears after a median of 10–11 months following the primary lesion [10, 28]. SPT reaches a peak between 5–24 months after the lesion [28, 29].

Recently, Shaikh et al. proposed a dual oscillator model for the pathogenesis of oculopalatal tremor (OPT) [30].Oculopalatal tremor refers to the synchronous combination of PT and pendular nystagmus. In this interesting model, the interaction between an oscillator in the inferior olivary nucleus and a modulator in the cerebellum was proposed to be the trigger for OPT. The cerebellar cortex was proposed to be an amplifier of the ocular tremor without changing its frequency. However, Kattah et al. recently reported the observation of OPT without any HOD [31]. The maladaptive cerebellar plasticity can trigger an oculopalatal tremor even when the inferior olive is not the primary source of oscillation [31].

Pathogenesis of progressive ataxia and palatal tremor (PAPT)

There are limited studies available on the origin of the PAPT. Cilia et al. noticed an impairment of the dentato-rubro-olivary pathway and the nigrostriatal dopamine system in patients with idiopathic PAPT [32]. The authors concluded that the RN was involved in the pathophysiology of idiopathic PAPT. The inflammation of the GMT was postulated in PAPT [25, 33]. Recently, Mari et al. found an insoluble four-repeat (4R) tau deposition in the inferior olive of the medulla [34]. The authors hypothesised that this tau deposition could trigger the retrograde degeneration of the dentato-olivary fibers. This retrograde degeneration might cause secondary (deafferentation type) hypertrophic degeneration in other olivary neurons potentially through the loss of axon collaterals. Recently, more widespread 3R (repeat) and 4R tau deposition has been reported in the postmortem study of two patients with PAPT [7]. The current histopathological association of the sporadic PAPT with tau deposition points towards a primary neurodegenerative process [7, 28].

Causes of palatal tremor: (Table 1) [7, 8, 9, 10, 23, 27, 28, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68]

EPT is idiopathic. SPT can occur due to any lesion in the dentato-rubro-olivary pathway of the GMT [1, 23, 24, 25, 26, 27, 28]. The common causes of SPT are infarct (hemorrhagic or ischemic), tumour, vascular malformation, drugs and demyelination (Table 1) [24, 25, 26, 27, 28]. PAPT can be familial or sporadic [7, 10, 28, 32, 33, 62, 63, 64, 65, 66, 67, 68]. The familial causes of PAPT are Alexander’s disease, polymerase gamma gene (POLG) mutation, and spinocerebellar ataxia type 20 [28, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67]. Sporadic PAPT is likely to be neurodegenerative in origin.

Table 1

Causes of palatal tremor.

Symptomatic palatal tremor

I) Vascular/Ischemic:
  • Basilar artery occlusion [36]
  • Brainstem or cerebellar infarct/bleed/tumor
  • Vertebral artery dolichectasia [37]
  • Vascular malformation (Arteriovenous malformation, aneurysm) [24, 25, 26, 27, 28, 38]
II) Inflammatory/Demyelinating:
  • Multiple Sclerosis [39, 40]
  • Neurosarcoidosis [41]
  • Multifocal Leukoencephalopathy
  • Bechet’s disease [42]
III) Genetic:
  • Spinocerebellar ataxia [18, 43]
IV) Infectious:
  • Tick-borne meningoencephalitis/Listeria encephalitis [44, 45]
  • Whipple disease [46]
V) Neoplastic:
  • Intestinal lymphoma [47]
  • Posterior fossa tumour
VI) Neurodegenerative:
  • Progressive supranuclear palsy [48]
VI) Miscellaneous:
  • Traumatic brain injury [49]
  • Amyotrophic Lateral Sclerosis [50]
  • Drugs (Ciprofloxacin/Lithium/Carbamazepine) [51, 52]
  • Epilepsy [53]
  • Hashimoto encephalopathy [54, 55]
  • Anti -GAD antibodies mediated encephalitis [56]
Progressive Ataxia and Palatal Tremor (PAPT)

I) Sporadic:
  • Tauopathy [7]
  • Gluten sensitive ataxia [33]
  • Vascular malformation [57]
II) Familial/genetic:
  • Alexander disease [58, 59]
  • Spinocerebellar Ataxia –20 (SCA 20) [60, 61]
  • POLG mutation [62, 63]
  • Hereditary spastic paraparesis type 7 (HSP-7) [64, 65]
  • GM2 Gangliosidosis [66]
  • Neuroferritinopathy [67]
  • Cerebrotendinous Xanthomatosis [68]

Clinical features (Table 2)

I) Essential Palatal tremor (EPT)

Table 2

Additional clinical features of various subtypes of palatal tremor.

Essential Palatal Tremor

Audible ear clicking [3, 23]
Symptomatic Palatal Tremor [6, 23, 24, 25, 26, 27, 28]

Holmes tremor
Oromandibular tremor
Throat clicking
Optic atrophy
Ocular tremor
Facial myokymia
Epilepsy partialis continua
Intranuclear ophthalmoplegia
Progressive Ataxia and Palatal Tremor (PAPT) [7, 10, 28, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67]

Pendular nystagmus/oscillopsia
Hypermetric and hypometric saccades
Optic atrophy (SPG 7, POLG mutation)
Movement disorders (chorea, dystonia, parkinsonism, myoclonus – SPG 7, SCA 20, Neuroferritinopathy, POLG mutation)
Pyramidal tract signs (hemiparesis, paraparesis – SCA 20, SPG 7 mutation)
Neuropathy (SPG 7, POLG)
Cognitive impairment (POLG mutation, Alexander disease, Neuroferritinopathy)
Seizure (POLG mutation, Alexander disease)
Hearing loss (mainly in sporadic PAPT)
Muscle disorders (POLG mutation)
Dysphonia (SCA 20)
Dysmorphic feature (GM2 Gangliosidosis)
Macrocephaly (Alexander disease)
Diarrhea (celiac disease, GM2 Gangliosidosis)
Hypogonadism, stroke like episodes (POLG mutation)


EPT: Essential palatal tremor.

SPT: Symptomatic palatal tremor.

PAPT: Progressive ataxia and palatal tremor.

SPG 7: genetic mutation responsible for hereditary spastic paraparesis.

SCA 20: Spinocerebellar ataxia 20.

POLG: Polymerase gamma gene.

Although TVP is the main muscle involved in the generation of the EPT, the contraction of other muscles like the oropharyngeal muscles, masseter and temporalis were also reported [28].

Zadikoff et al. reviewed the existing literature on EPT and found a male: female ratio of 1:1 [3]. Deuschl et al. reported the persistence of EPT during sleep in 50% of patients [3].The frequency of EPT is not only highly variable among different patients but it can also vary within a single individual [3, 28].

An audible ear click was reported very commonly with EPT [3, 23, 28]. The ear click is produced by the contractions of the TVP muscle that opens the eustachian tube, causing a sudden decrease in the surface tension within the tube [3, 23]. The ear click can be audible or inaudible, unilateral or bilateral. Some people have learned to elicit or regulate the frequency and volume of EPT [19]. The ear-clicking has been described as ticking, banging, cracking, popping, clattering, crunching or crackling noises [3]. Sometimes the ear click can be very distressing. EPT can show distractibility and entrainment during the clinical examination, which is suggestive of a functional or psychogenic element. Although sensory tricks like pressing over the mastoid or adopting certain neck positions were reported to reduce the tremor, such manoeuvres probably worked by altering the position and tone of the muscles involved or by changing the pressure in the ear canal [3].

II) Symptomatic palatal tremor (Table 2)

Since SPT happens due to a lesion in the GMT, many clinical features can be seen other than palatal tremor [23, 24, 25, 26, 27, 28]. Common associated clinical features reported were ophthalmoplegia, oculopalatal tremor, rubral or Holmes tremor, dysarthria, dysphagia and ataxia. Since SPT is commonly found in patients with an ischemic or hemorrhagic infarct, pyramidal tract signs can also be seen. Pendular nystagmus can be seen in up to 30% of cases with SPT [28]. The rarer clinical features reported were optic atrophy, vertical gaze paresis, facial dyskinesia, seizure and encephalopathy. Ophthalmoplegia was observed more frequently in unilateral HOD while ocular myoclonus and generalised myoclonus was observed in patients with bilateral HOD [27]. Ear clicking is rare in SPT [28]. However, tremors can also be observed in other derivatives of the branchial arch like the larynx, pharynx or diaphragm [28]. PAPT shows the relentless progression of ataxia. Sporadic PAPT reveals abnormal eye findings (saccadic pursuit, pendular nystagmus), oscillopsia and progressive ataxia

EPT can be distinguished from the SPT by the presence of an audible click, the variability of the tremors, the disappearance of tremors during sleep (50% cases), a lack of other clinical signs (ataxia, tremor and ophthalmoplegia) and a lack of any structural lesions (HOD) in MRI brain in EPT.

Table 3 summarises the important differences between EPT and SPT (pathogenesis, muscles involved, clinical features and investigations etc).

Table 3

The differences among the various subtypes of palatal tremor.

Essential Palatal Tremor (EPT) Symptomatic Palatal Tremor (SPT) Progressive ataxia with Palatal Tremor (PAPT)

Main muscle involved in the generation of tremor [3, 23] Tensor veli palatini Levator veli palatini Levator veli palatini
Nerve supply of the main muscle [3, 23] 5%th cranial nerve 9%th and 10%th cranial nerves 9%th and 10%th cranial nerve
Abnormal reflex types [23] Polysynaptic Monosynaptic, oligosynaptic and polysynaptic Not known
Relationship with sleep [23] Disappears in 50% cases Persists Persists
Effect of anaesthesia on tremor disappears persists Not known
Auditory signs Audible ear click -Common Audible ear click-rare Tinnitus, sensorineural hearing loss
Audible ear click – rare (familial)
Ocular signs Rare Can be seen Torsional and horizontal nystagmus, INO, hypermetric saccades, reduced VOR, vertical gaze palsy, optic atrophy
Other clinical features Rare except the ear click,
entrainment common
Ataxia, tremor, dysarthria etc – not entrainable Familial PAPT – additional pyramidal tract signs like tetraparesis, progressive ataxia, chorea, dystonia, cognitive impairment, autonomic dysfunction, tendon xanthoma
Sporadic PAPT: dysarthria, dysphagia
Cause Unknown Sporadic -any Lesion (infarct, bleed, tumour etc) within the Guillain Mollaret triangle of brainstem or idiopathic/neurodegenerative Familial/genetic – (POLG mutation, Alexander disease, Celiac disease, Cereberotendinous Xathomatosis, Celiac disease, GM2 Gangliosidosis)
Sporadic-Neurodegenerative/tauopathy/MSA/Gluten sensitive
Magnetic resonance imaging of brain No structural deficit Hypertrophic olivary degeneration of medulla Familial -significant brainstem atrophy but no HOD, dark dentate nucleus, cerebellar atrophy, iron accumulation in basal ganglia (Neuroferritinopathy)
White matter lesion with frontal predominance
(Alexander disease)
Sporadic PAPT-HOD

Investigations (Table 4)

The diagnosis of EPT is mainly clinical but investigations can be helpful in SPT. Routine blood tests are usually less informative although some specific blood tests like Lyme serology, celiac screening, Angiotensin-converting enzyme (ACE; for neurosarcoidosis), cholestanol and bile alcohol (cerebrotendinous xanthomatosis), anti-GAD antibodies (glutamatic acid decarboxylase; GAD encephalitis) and anti-thyroid peroxidase (TPO) antibodies (Hashimoto’s encephalopathy) can be helpful to identify the causes of SPT in the right clinical context [33, 40, 41, 55, 56, 68]. The cerebrospinal fluid study can be helpful to rule out malignancy (lymphoma) or to help in the clinical diagnosis of multiple sclerosis (presence of an unmatched oligoclonal band), neurosarcoidosis (ACE) and Whipple’s disease. Similarly, genetic testing for spinocerebellar ataxia (SCA 18 & 20), hereditary spastic paraparesis type 7 (caused by SPG 7 gene mutation), Alexander’s disease (glial fibrillary acid protein) and POLG mutation (mitochondrial disorders) can be helpful in reference to familial PAPT [43, 58, 60, 61, 63, 64, 65]. A surface electromyogram (EMG) can be useful to measure the frequency of the palatal tremor. Similarly, in some patients with PAPT (SCA20, HSP7 and mitochondrial disorders), a nerve conduction study can reveal axonal neuropathy.

The most characteristic finding shown on the MRI of the head of patients with SPT and sporadic PAPT is the HOD of the medulla [10, 11, 23, 24, 25, 26, 27, 28, 29, 30, 32, 33, 35, 69]. As mentioned before, the HOD is a transsynaptic degeneration of the inferior olivary nucleus of the medulla because of a lesion within the boundary of the GM triangle [24, 25, 26, 69]. The HOD can be unilateral or bilateral (Figure 2) [24, 25, 26]. A bilateral HOD is more likely to be idiopathic [25, 26, 27]. Four different patterns of HOD were described in the literature based on the location of the primary lesion. They were an ipsilateral HOD with a primary lesion in the brainstem, a contralateral HOD with a primary lesion in the cerebellum/cerebellar peduncle, a bilateral HOD with both CTT affected by a midline lesion and a bilateral HOD with the primary lesion in the cerebellum or unilateral brainstem [26].

Figure 2 

Axial T2 Weighted Fluid Attenuated Inversion Recovery (FLAIR) Magnetic Resonance Imaging (MRI) shows Increased Signal of the Inferior Olivary nucleus of the Right Hemi-medulla (black arrow) Suggestive of the Hypertrophic Olivary Degeneration.

The familial variant of PAPT shows brainstem and cervical cord atrophy but no HOD [10, 68, 70]. Sporadic PAPT shows mostly bilateral HOD. One study revealed hemosiderin in the T2 gradient Echo MRI brain in sporadic PAPT due to superficial hemosiderosis [57]. The same study found a brainstem vascular malformation in 3 patients. When Alexander’s disease causes PAPT in adults, the ‘tadpole’ pattern of brainstem atrophy can be found [71].

Goyal et al. detailed three distinct phases of the MRI corresponding to the pathological changes of the HOD [69]. The first stage is the increased T2 signal in the ION without hypertrophy after 4–6 months of the initial insult. The second stage is the increased T2 signal and ION hypertrophy that resolves in 3–4 years after the lesion. During the third stage, the olivary hypertrophy starts to disappear. The atrophy begins after a few years and the olivary shrinkage becomes apparent. However, the increased T2 signal of the MRI may persist. Recently, diffusor tensor imaging (DTI), an advanced MRI technique, has been able to show the specific disruption in the various components of the GM triangle [72]. The DTI revealed probable demyelination in the late stages of the HOD.

Figure 3 provides as algorithmic approach to investigating the various subtypes of palatal tremor.

Figure 3 

Algorithmic Approach to the Investigation of Palatal Tremor.


The literature is sparse so far as the treatment of palatal tremor is concerned. EPT was reported to be responsive to clonazepam, carbamazepine, phenytoin, valproate, gabapentin, flunarizine, lamotrigine, trihexyphenidyl, sumatriptan and botulinum toxin [73]. Pandurangi et al. reported an 80% improvement in ear click and a significant improvement of the essential palatal tremor with clonazepam (up to 3 mg/day) [74]. Borggreve et al. reported the complete resolution of essential palatal tremor within a few days of valproate intake [13]. Cakmur et al. reported the complete resolution of EPT after starting on flunarizine and the same patient only had a partial response to valproate before [14]. Scott et al. reported the abolition of essential palatal tremor after the administration of oral and subcutaneous sumatriptan [75]. However, another case report found no response to sumatriptan [76]. Jabbari et al. noticed that there was a good response to the anticholinergic Trihexyphenidyl [77]. However, Fabini et al. reported no improvement of EPT with valproate, carbamazepine, levodopa in one patient with EPT but the resolution of EPT with high dose clonazepam (12 mg/day) in another patient [78]. One case report observed the slowing down of the essential palatal tremor with lamotrigine (125 mg twice daily) [12]. Piracetam was found to be effective in childhood onset EPT though the tremor recurred when piracetam was stopped [79]. Cognitive behavioural therapy can also be helpful [80]. The injection of botulinum toxin into the TVP can help to reduce the tremor and ear clicking noise [81, 82]. Low doses (e.g. onabotulinumtoxin A – 4 to 30 U mainly) were injected under EMG guidance to treat the symptomatic ear click [81, 82]. The botulinum toxin was found to be more effective in the paediatric age group [83]. Radiofrequency ablation can also be effective at abolishing a tremor of the soft palate [84].

A palatal tremor usually does not bother the patient although any associated oscillopsia or ataxia can be disabling. Gabapentin and memantine could be helpful to reduce the oscillopsia in an oculopalatal tremor [28, 85]. The treatment of SPT involves the treatment of the associated medical cause (if possible) or the surgical removal of any underlying lesion. Cheung et al. reported the resolution of ciprofloxacin-induced PT with valproate [51]. However, it is difficult to gauge to what extent the discontinuation of Ciprofloxacin contributed to the resolution of the tremor. Iwasaki et al. reported a significant improvement of palatal myoclonus (tremor) in a patient with Bechet’s disease through the use of ceruletide, a cholecystokinin-like peptide [42]. The botulinum toxin injection was effective at reducing symptomatic PT in tick-borne meningoencephlitis [45]. Salazar et al. reported on the prophylactic role of levetiracetam at eliminating the risk of palatal tremor after a cortical ischemic infarct of the brain [86]. Marnane et al. reported new-onset epilepsy with palatal tremors due to the anti-glutamic acid decarboxylase antibodies that responded to intravenous immunoglobulin [56].

There is no known therapy to halt the progression of ataxia in PAPT although ataxia in one patient improved with a gluten-free diet [33]. Rossi et al. reported a mild improvement of gait instability but not the palatal tremor after treatment with chenodeoxycholic acid in a patient with PAPT secondary to cerebrotendinous xanthomatosis [68]. Nasal sumatriptan 20 mg temporarily helped palatal tremor although lamotrigine and clonazepam were found to be ineffective [70]. Drugs that can reduce the electronic coupling among the hypetrophic olivary neurons by blocking the connections (quinine or mefloquine) are suggested to control the symptoms although no study is available to support this [28].

Surgery had a limited role in the treatment of palatal tremor (except in the removal of any underlying lesion in the GMT). The surgical perforation of the tympanic membrane and the excision of the LVP, TVP and tensor tympani muscle did not provide any obvious benefit [82]. A thalamotomy also did not provide benefit in a patient with both PT and Holmes’ tremor [87]. The bilateral deep brain stimulation of the red nucleus did not reduce OPT in one patient [28]. However, one group reported the resolution of palatal tremor with no recurrence for 5 years after stereotactic ablative surgery involving the zona incerta of the right subthalamus and the nucleus ventralis intermedius of the right thalamus (VIM) [38].

Conclusion and future directions

Whether the term ‘isolated palatal tremor’ instead of the ‘essential palatal tremor’ would better represent the varied aetiologies or not needs to be settled. PAPT should be classified as a separate category of PT to maintain a consistency in the descriptions in the literature and to better facilitate future research. Further studies are also needed to understand the relationship between mitochondrial disorders and HOD. This is as mitochondrial disorders are found to have caused PAPT. Similarly, the relationship between tau inclusions (3 repeat or 4 repeat) and sporadic PAPT needs to be explored further. Combined clinical and autopsy studies would be more helpful to find the actual causes of HOD as many patients with bilateral HOD show no clear underlying aetiology. The more widespread use of Diffusor Tensor Imaging (DTI) and magnetic resonance imaging in the future would throw more light on the pathophysiology of palatal tremors. Although PT usually does not bother the patients, ataxia, nystagmus or oscillopsia can be disabling. Future studies are needed to explore new therapeutic approaches as the current management for the aforementioned symptoms is unsatisfactory.

Competing Interests

The author has no competing interests to declare.

Author Contribution

1. Study concept and design, acquisition of data, analysis and interpretation of data, study supervision, critical revision of manuscript for intellectual content, analysis and interpretation of data.


  1. Kamble N, Pal PK. Tremor syndromes: A review. Neurol India. 2018; 66: S36–S47. DOI: 

  2. Deuschl G, Bain P, Brin M and An adhoc scientific committee. Consensus statement of the Movement Disorders Society on tremor. Mov Disord. 1998; 13(suppl 3): 2–23. DOI: 

  3. Zadikoff C, Lang AE, Klein C. The ‘essentials’ of essential palatal tremor: A reappraisal of the nosology. Brain. 2006; 129: 832–840. DOI: 

  4. Shaikh AG, Riley DE, Gunzler SA. Teaching video neuroimages: essential palatal tremor: Is it a peripherally triggered central movement disorder? Neurology. 2012; 79: e142. DOI: 

  5. Stern MM. Rhythmic palatopharyngeal myoclonus. J Nerv Ment Dis. 1949; 109: 48–53. DOI: 

  6. Samuel M, Kleiner-Fisman G, Lang AE. Voluntary control and a wider clinical spectrum of essential palatal tremor. Mov Disord. 2004; 19: 717–719. DOI: 

  7. Gao AF, Faust-Socher A, Al-Murshed M, Del Bigio MR, Lang AE, Munoz DG. Progressive ataxia and palatal tremor: Two autopsy cases of a novel tauopathy. Mov Disord. 2017; 32: 1465–1473. DOI: 

  8. Peikert K, Gerber J, Winzer S, Schäfer J, Reichmann H, Hermann A. Palatal Tremor with Progressive Ataxia Secondary to A Dural Arteriovenous Fistula. Mov Disord Clin Pract. 2019; 6(4): 327–329. DOI: 

  9. Eggenberger E, Cornblath W, Stewart DH. Oculopalatal tremor with tardive ataxia. J Neuroophthalmol. 2001; 21: 83–86. DOI: 

  10. Samuel M, Torun N, Tuite PJ, Sharpe JA, Lang AE. Progressive ataxia and palatal tremor (PAPT): Clinical and MRI assessment with review of palatal tremors. Brain. 2004; 127: 1252–1268. DOI: 

  11. Nitschke MF, Krüger G, Bruhn H, Klein C, Gehrking E, Wessel K, Frahm J, Vieregge P. Voluntary palatal tremor is associated with hyperactivation of the inferior olive: A functional magnetic resonance imaging study. Mov Disord. 2001; 16: 1193–1195. DOI: 

  12. Nasr A, Brown N. Palatal myoclonus responding to lamotrigine. Seizure. 2002; 11: 136–137. DOI: 

  13. Borggreve F, Hageman G. A case of idiopathic palatal myoclonus: Treatment with sodium valproate. Eur Neurol. 1991; 31: 403–404. DOI: 

  14. Cakmur R, Idiman E, Idiman F, Baklan B, Ozkiziltan S. Essential palatal tremor successfully treated with flunarizine. Eur Neurol. 1997; 38: 133–134. DOI: 

  15. Wakata N, Sugimoto H, Iguchi H, Nomoto N, Ohgoshi T. A case of voluntary palatal myoclonus with ear click: Relationship between palatal myoclonus and click. Eur Neurol. 2002; 48: 52–53. DOI: 

  16. Gupta OP, Samant HC, Katiyar BC. Velo-pharyngo-laryngeal myoclonia with objective tinnitus. Eye Ear Nose Throat Mon. 1972; 51: 306–309. 

  17. Kadakia S, McAbee G. Volitional control of palatal myoclonus. Mov Disord. 1990; 5: 182–183. 

  18. Ross S, Jankovic J. Palatal myoclonus: An unusual presentation. Mov Disord. 2005; 20: 1200–1203. DOI: 

  19. Klein C, Gehrking E, Vieregge P. Voluntary palatal tremor in two siblings. Mov Disord. 1998; 13: 545–548. DOI: 

  20. Williams DR. Psychogenic palatal tremor. Mov Disord. 2004; 19: 333–335. DOI: 

  21. Schrag A, Lang AE. Psychogenic movement disorders. Curr Opin Neurol. 2005; 18: 399–404. DOI: 

  22. Stamelou M, Saifee TA, Edwards MJ, Bhatia KP. Psychogenic palatal tremor may be underrecognized: Reappraisal of a large series of cases. Mov Disord. 2012; 27: 1164–1168. DOI: 

  23. Deuschl G, Toro C, Valls-Solé J, Zeffiro T, Zee DS, Hallett M. Symptomatic and essential palatal tremor. Clinical, physiological and MRI analysis. Brain. 1994; 117: 775–788. DOI: 

  24. Choh NA, Choh SA, Jehangir M. Hypertrophic olivary degeneration. The forgotten triangle of Guillain and Mollaret. Neurol. India. 2009; 57: 507–509. DOI: 

  25. Konno T, Broderick DF, Tacik P, Caviness JN, Wszolek ZK. Hypertrophic olivary degeneration: A clinico-radiologic study. Parkinsonism Relat Disord. 2016; 28: 36–40. DOI: 

  26. Wang H, Wang Y, Wang R, Li Y, Wang P, Li J, Du J. Hypertrophic olivary degeneration: A comprehensive review focusing on etiology. Brain Res. 2019; 1718: 53–63. DOI: 

  27. Nagappa M, Bindu PS, Sinha S, Bharath RD, Sanshya M, Saini J, et al. Palatal Tremor Revisited: Disorder with Nosological Diversity and Etiological Heterogeneity. Can J Neurol Sci. 2018; 45: 243–247. DOI: 

  28. Tilikete C, Desestret V. Hypertrophic olivary degeneration and palatal or oculopalatal tremor. Front Neurol. 2017; 8: 302. DOI: 

  29. Nishie M, Yoshida Y, Hirata Y, Matsunaga M. Generation of symptomatic palatal tremor is not correlated with inferior olivary hypertrophy. Brain. 2002; 125: 1348–1357. DOI: 

  30. Shaikh AG, Hong S, Liao K, Tian J, Solomon D, Zee DS, et al. Oculopalatal tremor explained by a model of inferior olivary hypertrophy and cerebellar plasticity. Brain. 2010; 133: 923–940. DOI: 

  31. Kattah JC, Elble RJ, De Santo J, Shaikh AG. Oculopalatal tremor following sequential medullary infarcts that did not cause hypertrophic olivary degeneration. Cerebellum Ataxias. 2020; 7: 3. DOI: 

  32. Cilia R, Righini A, Marotta G, Benti R, Marconi R, Isaias IU, Pezzoli G, Antonini A. Clinical and imaging characterization of a patient with idiopathic progressive ataxia and palatal tremor. Eur J Neurol. 2007; 14(8): 944–946. DOI: 

  33. Kheder A, Currie S, Romanowski C, Hadjivassiliou M. Progressive ataxia with palatal tremor due to gluten sensitivity. Mov Disord. 2012; 27(1): 62–63. DOI: 

  34. Mari Z, Halls AJM, Vortmeyer A, et al. Clinico-Pathological Correlation in Progressive Ataxia and Palatal Tremor: A Novel Tauopathy. Mov Disord Clin Pract. 2014; 1: 50–56. DOI: 

  35. Onen MR, Moore K, Cikla U, Ucer M, Schmidt B, Field AS, Baskaya MK. Hypertrophic olivary degeneration Neurosurgical perspective and literature review. World Neurosurg. 2018; 112: e763–e771. DOI: 

  36. Bulwa Z, Biller J. Palatal tremor and hypertrophic olivary degeneration as sequelae of basilar artery occlusion. Neurol Clin Pract. 2019; 9: e30–e32. DOI: 

  37. Vanikieti K, Cheecharoen P, Jindahra P, Lueangaram S, Padungkiatsagul T. Atypical oculopalatal tremor as the presentation of vertebral artery dolichoectasia. Int Med Case Rep J. 2016; 9: 273–77. DOI: 

  38. Menéndez DF, Cury RG, Barbosa ER, Teixeira MJ, Fonoff ET. Hypertrophic olivary degeneration and holmes’ tremor secondary to bleeding of cavernous malformation in the midbrain. Tremor Other Hyperkinet Mov (N Y). 2014; 4: 264. DOI: 

  39. Tranchant C, Bhatia KP, Marsden CD. Movement disorders in multiple sclerosis. Mov Disord. 1995; 10: 418–423. DOI: 

  40. Revol A, Vighetto A, Confavreux C, Trillet M, Aimard G. Myoclonies oculo-vélo-palatines et sclérose en plaques [Oculo-palatal myoclonus and multiple sclerosis]. Rev Neurol (Paris). 1990; 146(8–9): 518–521. 

  41. Sidiropoulos C, Sripathi N, Nasrallah K, Mitsias P. Oculopalatal tremor, facial myokymia and truncal ataxia in a patient with neurosarcoidosis. J Clin Neurosci. 2014; 21: 2255–2256. DOI: 

  42. Iwasaki Y, Kinoshita M, Ikeda K, Shiojima T. Palatal myoclonus following Bechet’s disease ameliorated by ceruletide, a potent analogue of CCK octapeptide. J Neurol Sci. 1991; 105(1): 12–13. DOI: 

  43. Echeveste B, Covarrubias E, Cabello JP, Luquin MR. Isolated palatal tremor as unique clinical manifestation of SCA 18 due to a new mutation of IFRD1. Parkinsonism & Related Disorders. 2017 Sep; 42: 100–101. DOI: 

  44. Chhetri SK, Dayanandan R, Bindman DC, Mathur S, Mills RJ. Symptomatic palatal tremor following multiple listerial brainstem abscesses. Parkinsonism Relat Disord. 2014; 20: 253–235. DOI: 

  45. Pogorzelski R, Drozdowski W, Rogowski M. Symptomatic palatal myoclonus with ear click after tick-borne meningoencephalitis. Eur Arch Otorhinolaryngol. 2006; 263: 711–713. DOI: 

  46. Quinn N. Rhythmic tremor of the palate and other cranial limb muscles, with cerebellar ataxia: Consider Whipple’s disease. Mov Disord. 2001; 16: 787. DOI: 

  47. Gambardella A, Zappia A, Valentino P, Aguglia U, Fera F, Pardatscher K, Quattrone A. Action palatal tremor in a patient with primary intestinal lymphoma. Mov Disord. 1997; 12: 794–797. DOI: 

  48. Berlot R, Kojović M. Palatal tremor in progressive supranuclear palsy: A case report. Parkinsonism Relat Disord. 2015; 21: 335–336. DOI: 

  49. Sharma P, Eesa M, Poppe AY, Goyal M. Teaching NeuroImage: Posttraumatic palatal tremor. Neurology. 2008; 71: e30. DOI: 

  50. Maghzi AH, Sahai S, Zimnowodzki S, Baloh RH. Palatal tremor as a presenting symptom of amyotrophic lateral sclerosis. Neurology. 2018; 90: 801–802. DOI: 

  51. Cheung YF, Wong WW, Tang KW, Chan JH, Li PC. Ciprofloxacin-induced palatal tremor. Mov Disord. 2007; 22: 1038–1043. DOI: 

  52. Mahasuar R, Kuruvilla A, Jacob K. Palatal tremor after lithium and carbamazepine use: A case report. J Med Case Rep. 2010; 4: 176. DOI: 

  53. Jung HJ, Choi SM, Lee JK, Lee SH, Kim BC. Palatal tremor as a manifestation of epilepsia partialis continua caused by acute precentral gyral infarction. J Clin Neurosci. 2013; 20: 1460–1461. DOI: 

  54. Ghoreishi E, Shahidi GA, Rohani M, Nabavi M, Aghaei M, Akhoundi FH. Palatal-Myoclonus as a Presentation of Hashimoto Encephalopathy: An interesting case report. Iran J Psychiatry. 2013; 8: 149–151. 

  55. Erickson JC, Carrasco H, Grimes JB, Jabbari B, Cannard KR. Palatal tremor and myorhythmia in Hashimoto’s encephalopathy. Neurology. 2002; 58: 504–505. DOI: 

  56. Marnane M, Vincent A, Hutchinson M. New-onset focal epilepsy with palatal tremor and glutamic acid decarboxylase antibodies responding to intravenous immunoglobulin. J Neurol. 2008; 255: 1603–1604. DOI: 

  57. Kumar N, Eggers SD, Milone M, Keegan BM. Acquired progressive ataxia and palatal tremor: Importance of MRI evidence of hemosiderin deposition and vascular malformations. Parkinsonism Relat Disord. 2011; 17: 565–568. DOI: 

  58. Gass JM, Cheema A, Jackson J, Blackburn PR, Van Gerpen J, Atwal PS. Novel GFAP Variant in Adult-onset Alexander Disease with Progressive Ataxia and Palatal Tremor. Neurologist. 2017; 22: 247–248. DOI: 

  59. Sebesto JR, van Gerpen JA. Teaching Video NeuroImages: Palatal tremor in adult-onset Alexander disease. Neurology. 2016 Jun 14; 86: e252. DOI: 

  60. Storey E, Gardner RJ. Spinocerebellar ataxia type 20. Handb Clin Neurol. 2012; 103: 567–73. DOI: 

  61. Knight MA, Gardner RJ, Bahlo M, et al. Dominantly inherited ataxia and dysphonia with dentate calcification: Spinocerebellar ataxia type 20. Brain. 2004; 127(Pt 5): 1172–1181. DOI: 

  62. Mongin M, Delorme C, Lenglet T, Jardel C, Vignal C, Roze E. Progressive Ataxia and Palatal Tremor: Think about POLG Mutations. Tremor Other Hyperkinet Mov (N Y). 2016; 6: 382. DOI: 

  63. Johansen KK, Bindoff LA, Rydland J, Aasly JO. Palatal tremor and facial dyskinesia in a patient with POLG1 mutation. Mov Disord. 2008; 23: 1624–1626. DOI: 

  64. Gass J, Blackburn PR, Jackson J, Macklin S, van Gerpen J, Atwal PS. Expanded phenotype in a patient with spastic paraplegia 7. Clin Case Rep. 2017; 5: 1620–1622. DOI: 

  65. Primiano G, Zanni G, Nardella M, Servidei S. Teaching Video NeuroImages: Palatal tremor associated with SPG7 variants. Neurology. 2020; 94(19): e2074–e2075. DOI: 

  66. Pretegiani E, Rosini F, Federighi P, Cerase A, Dotti MT, Rufa A. Pendular nystagmus, palatal tremor and progressive ataxia in GM2-gangliosidosis. Eur J Neurol. 2015; 22: e67–9. DOI: 

  67. Wills AJ, Sawle GV, Guilbert PR, Curtis AR. Palatal tremor and cognitive decline in neuroferritinopathy. J Neurol Neurosurg Psychiatry. 2002; 73: 91–92. DOI: 

  68. Rossi M, Cesarini M, Gatto EM, Cammarota A, Merello M. A Treatable Rare Cause of Progressive Ataxia and Palatal Tremor. Tremor Other Hyperkinet Mov (N Y). 2018; 8: 538. DOI: 

  69. Goyal M, Versnick E, Tuite P, Cyr JS, Kucharczyk W, Montanera W, Willinsky R, Mikulis D. Hypertrophic olivary degeneration: Metaanalysis of the temporal evolution of MR findings. AJNR Am J Neuroradiol. 2000; 21: 1073–1077. 

  70. Pradeep S, Grewal P, Jahan S, Raslau FD, Slevin JT. Pearls & Oy-sters: Progressive ataxia and palatal tremor: Imaging and disease course. Neurology. 2020; 94: e1445–e1447. DOI: 

  71. Namekawa M, Takiyama Y, Honda J, Shimazaki H, Sakoe K, Nakano I. Adult-onset Alexander disease with typical “tadpole” brainstem atrophy and unusual bilateral basal ganglia involvement: A case report and review of the literature. BMC Neurol. 2010; 10: 21. DOI: 

  72. Shah R, Markert J, Bag AK, Curé JK. Diffusion tensor imaging in hypertrophic olivary degeneration. AJNR Am J Neuroradiol. 2010; 31: 1729–1731. DOI: 

  73. Deuschl G, Fasano A. Essential Tremor and Other Tremors, In: Schapira AHV, Lang AET, Fahn S (eds.), Blue Books of Neurology. 2010; 506–557. London: Elsevier. DOI: 

  74. Pandurangi AA, Nayak RB, Bhogale GS, Patil NM, Chate SS, Chattopadhaya S. Clonazepam in the treatment of essential palatal tremors. Indian J Pharmacol. 2012; 44: 528–530. DOI: 

  75. Scott BL, Evans RW, Jankovic J. Treatment of palatal myoclonus with sumatriptan. Mov Disord. 1996; 6: 748–751. DOI: 

  76. Pakiam AS, Lang AE. Essential palatal tremor: Evidence of heterogeneity based on clinical features and response to Sumatriptan. Mov Disord. 1999; 14: 179–180. DOI:<179::AID-MDS1038>3.0.CO;2-I 

  77. Jabbari B, Scherokman B, Gunderson CH, Rosenberg ML, Miller J. Treatment of movement disorders with trihexyphenidyl. Mov Disord. 1989; 4(3): 202–212. DOI: 

  78. Fabiani G, Teive HA, Sa D, Kay CK, Scola RH, Martins M, et al. Palatal myoclonus: Report of two cases. Arq Neuropsiquiatr. 2000; 58: 901–904. DOI: 

  79. Campistol-Plana J, Majumdar A, Fernández-Alvarez E. Palatal tremor in childhood: Clinical and therapeutic considerations. Dev Med Child Neurol. 2006; 48: 982–984. DOI: 

  80. Kitamura T, Sato T, Hayashi N, Fukushima Y, Yoda T. Essential Palatal Tremor Managed by Cognitive Behavioral Therapy. Case Rep Dent. 2015; 2015: 414620. DOI: 

  81. Penney SE, Bruce IA. Saeed SR: Botulinum toxin is effective and safe for palatal tremor: A report of five cases and a review of the literature. J Neurol. 2006. 253: 857–860. DOI: 

  82. Arora V, Smith M. Palatal myoclonus: A long follow-up experience. Indian J Otol. 2015; 21: 294–297. DOI: 

  83. Krause E, Leuning A, Heinen F, Gurkov R. Difference in outcome of botulinum toxin treatment of essential palatal tremor in children and adults. Am J Otolaryngol. 2010; 31: 91–95. DOI: 

  84. Aydin O, Iseri M, Ozturk M. Radiofrequency ablation in the treatment of idiopathic bilateral palatal myoclonus: A new indication. Ann Otol Rhinol Laryngol. 2006; 115: 824–826. DOI: 

  85. Shaikh AG, Thurtell MJ, Optican LM, Leigh RJ. Pharmacological tests of hypotheses for acquired pendular nystagmus. Ann N Y Acad Sci. 2011; 1233: 320–6. DOI: 

  86. Salazar R, Miller D. Symptomatic palatal tremor of cortical origin due to stroke. J Clin Neurosci. 2013; 20: 757–759. DOI: 

  87. Maki F, Sato S, Watanabe K, Yanagisawa T, Hagiwara Y, Shimizu T, Hasegawa Y. Vim thalamotomy in a patient with Holmes’ tremor and palatal tremor – Pathophysiological considerations. BMC Neurol. 2015; 15: 26. DOI: 

comments powered by Disqus